{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:07:06Z","timestamp":1789020426811,"version":"build-2803163510"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>\n                    This study reports a pediatric patient harboring the heterozygous\n                    <jats:italic>CDC42<\/jats:italic>\n                    variant (c. 203G\u2009&amp;gt;\u2009A, p. Arg68Gln), an ultra-rare variant with limited clinical and genetic data worldwide. She presented with typical Takenouchi-Kosaki syndrome (TKS) manifestations, including severe growth retardation, characteristic craniofacial dysmorphism, persistent macrothrombocytopenia and progressive sensorineural hearing loss. Additional evaluations identified leukopenia, hypogammaglobulinemia and a humoral immunodeficiency. Compound heterozygous\n                    <jats:italic>GJB2<\/jats:italic>\n                    variants were detected but unlikely to dominate the patient's profound hearing loss. Off-label recombinant human growth hormone (rhGH) therapy was administered for her short stature. During six months of follow-up, favorable catch-up growth was achieved. Literature review was conducted to clarify features of this variant. This study supplements the clinical data of the\n                    <jats:italic>CDC42<\/jats:italic>\n                    p. Arg68Gln variant, provides preliminary evidence for rhGH intervention, and offers reference information for the clinical management and genetic counseling of patients with TKS.\n                  <\/jats:p>","DOI":"10.3389\/fped.2026.1906125","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:31:53Z","timestamp":1789018313000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Clinical phenotypes and recombinant human growth hormone therapeutic exploration for a patient with Takenouchi-Kosaki syndrome harboring the CDC42 p.Arg68Gln variant"],"prefix":"10.3389","volume":"14","author":[{"given":"Xiao-xiao","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Pediatrics, The First Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-yuan","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The First Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-cheng","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The First Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Guangzhou University of Chinese Medicine First Affiliated Hospital","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3390\/genes15080974","article-title":"Auditory and language abilities in children with Takenouchi-Kosaki syndrome: a systematic review","volume":"15","author":"Caragli","year":"2024","journal-title":"Genes-Basel"},{"key":"B2","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nrm2476","article-title":"Mammalian Rho GTPases: new insights into their functions from in vivo studies","volume":"9","author":"Heasman","year":"2008","journal-title":"Nat Rev Mol Cell Bio"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1042\/BST20210112","article-title":"Progress in the therapeutic inhibition of CDC42 signalling","volume":"49","author":"Murphy","year":"2021","journal-title":"Biochem Soc T"},{"key":"B4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3390\/cells10020401","article-title":"Rho GTPase signaling in health and disease: a Complex signaling network","volume":"10","author":"Brakebusch","year":"2021","journal-title":"Cells-Basel"},{"key":"B5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajhg.2017.12.015","article-title":"Functional dysregulation of CDC42 causes diverse developmental phenotypes","volume":"102","author":"Martinelli","year":"2018","journal-title":"Am J Hum Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.bbrc.2016.01.111","article-title":"Rho GTPase protein CDC42 is critical for postnatal cartilage development","volume":"470","author":"Nagahama","year":"2016","journal-title":"Biochem Bioph Res Co"},{"key":"B7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nature01148","article-title":"Rho GTPases in cell biology","volume":"420","author":"Etienne-Manneville","year":"2002","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/jb\/mvaf021","article-title":"CDC42 missense mutations and human diseases: from neurodevelopmental disorders to autoinflammation","volume":"178","author":"Yasumi","year":"2025","journal-title":"J Biochem"},{"key":"B9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/21541248.2021.1885134","article-title":"Role of Rho-GTPases in megakaryopoiesis","volume":"12","author":"Vainchenker","year":"2021","journal-title":"Small GTPases"},{"key":"B10","doi-asserted-by":"publisher","first-page":"820945","DOI":"10.3389\/fcvm.2021.820945","article-title":"Turning platelets off and on: role of RhoGAPs and RhoGEFs in platelet activity","volume":"8","author":"Comer","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bonr.2016.01.001","article-title":"CDC42 is crucial for facial and palatal formation during craniofacial development","volume":"5","author":"Oshima-Nakayama","year":"2016","journal-title":"Bone Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ydbio.2013.09.013","article-title":"Inactivation of CDC42 in neural crest cells causes craniofacial and cardiovascular morphogenesis defects","volume":"383","author":"Liu","year":"2013","journal-title":"Dev Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.stem.2009.01.017","article-title":"Stage-specific control of neural crest stem cell proliferation by the small Rho GTPases CDC42 and Rac1","volume":"4","author":"Fuchs","year":"2009","journal-title":"Cell Stem Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/s0168-9525(01)02311-3","article-title":"Evolutionary expansion of CRIB-containing CDC42 effector proteins","volume":"17","author":"Pirone","year":"2001","journal-title":"Trends Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.1007\/s10875-021-01001-x","article-title":"Immune-mediated chronic macrothrombocytopenia, musculoskeletal abnormalities, and dysmorphic features in a patient with Takenouchi-Kosaki syndrome","volume":"41","author":"Stubbs","year":"2021","journal-title":"J. Clin. Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"104358","DOI":"10.1016\/j.ejmg.2021.104358","article-title":"Intermittent macrothrombocytopenia in a novel patient with Takenouchi-Kosaki syndrome and review of literature","volume":"64","author":"Santoro","year":"2021","journal-title":"Eur J Med Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41598-021-97478-y","article-title":"Macrothrombocytopenia of Takenouchi-Kosaki syndrome is ameliorated by CDC42 specific - and lipidation inhibitors in MEG-01 cells","volume":"11","author":"Daimon","year":"2021","journal-title":"Sci Rep-Uk"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1182\/blood-2009-09-242271","article-title":"Multiple alterations of platelet functions dominated by increased secretion in mice lacking CDC42 in platelets","volume":"115","author":"Pleines","year":"2010","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.jgg.2026.02.006","article-title":"Natural history and phenotype-genotype correlations in GJB2-related hearing loss: a systematic and comprehensive review","volume":"53","author":"Chen","year":"2026","journal-title":"J Genet Genomics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"bvaf149.1762","DOI":"10.1210\/jendso\/bvaf149.1762","article-title":"SAT-193 growing against the odds: growth hormone therapy in Costello syndrome - a case report","volume":"9","author":"Solomon","year":"2025","journal-title":"J Endocr Soc"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e71744","DOI":"10.1002\/ccr3.71744","article-title":"KBG syndrome: a case report and longitudinal assessment of long-acting recombinant human growth hormone therapy","volume":"14","author":"Nan","year":"2026","journal-title":"Clin Case Rep"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1906125\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:31:55Z","timestamp":1789018315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1906125\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":21,"alternative-id":["10.3389\/fped.2026.1906125"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1906125","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"1906125"}}